FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

188 letters match. Newest first.

  1. Cardinal Health

    Cardinal Health marketed convenience kits with unapproved syringes and lacked supplier qualification for infusion-pump-compatible Monoject syringes.

    High risk
  2. Royal Philips

    FDA warns Royal Philips over unvalidated supplier molding for CT monitor cable and unreported device corrections at Suzhou plant.

    High risk
  3. Soulaire Corporation

    FDA says Soulaire marketed an ECP device for unapproved uses without clearance or approval.

    High risk
  4. Beckman Coulter Inc.

    FDA warns Beckman Coulter over inadequate quality-system procedures for DxI 9000 immunoassay devices.

    High risk
  5. ReNovo, Inc. DBA Provision Device Reprocessing Solutions

    ReNovo, a device reprocessor in Bend, Oregon, sold new device models without required FDA clearances and had quality system failures.

    High risk
  6. Jiangsu Shenli Medical Production Co., Ltd.

    FDA says Jiangsu Shenli marketed many piston syringes in the U.S. without required clearance or approval.

    High risk
  7. Medline Industries, LP

    FDA warns Medline over uncleared syringes in surgical kits and unresolved design and complaint failures.

    High risk
  8. Exactech, Inc.

    Exactech shoulder and hip implants had quality-system and medical-device reporting failures, including a late GXL liner wear report.

    High risk
  9. Fresenius Kabi AG

    FDA warned Fresenius Kabi about quality and reporting failures for its Ivenix Infusion System.

    High risk
  10. Deymed Diagnostic s.r.o.

    Deymed Diagnostic s.r.o.'s BrainFeedback Pro, TruScan LT, and DuoMAG NL devices had quality system violations in design, complaints, production, and records.

    Medium
  11. Terragene S.A.

    Terragene S.A. made sterilization indicator devices with complaint-handling and MDR failures and uncleared extended-cycle claims.

    High risk
  12. Sonesta Medical AB

    FDA warned Sonesta Medical AB that its radiographic and cystometric tables violated device quality system rules.

    Medium
  13. Fresenius Medical Care AG & Co. KGaA

    FDA warns Fresenius over delayed fixes and reporting for PCB leaching from silicone tubing in hemodialysis machines.

    High risk
  14. Wello Inc.

    FDA cited Wello Inc. for misbranded welloStationX devices because labels lacked unique device identifiers and required GUDID data were not submitted.

    Low
  15. Ming Fai Industrial Co LTD

    Ming Fai Industrial, a Shenzhen device maker, lacked validation and acceptance-status controls for ultrasound gel and probe covers.

    High risk
  16. Acrostak Schweiz AG

    FDA warns Acrostak Schweiz that its M-Cath Flexy Microcatheter was marketed without required 510(k) clearance (FDA marketing permission) and has quality-system violations.

    High risk
  17. Abiomed Inc.

    Abiomed marketed Impella Connect System without PMA and had CGMP, complaint, and MDR reporting failures.

    High risk
  18. BYD Precision Manufacture Co., Ltd

    FDA warned BYD Precision Manufacture over quality-system and reporting failures for surgical masks and an N95 respirator made in Shenzhen, China.

    Medium
  19. Caltag Medsystems Ltd

    FDA warned Caltag Medsystems over quality-system failures in making TransFix/EDTA Vacuum Blood Collection Tubes.

    Medium
  20. Tesla BioHealing, Inc.

    FDA warns Tesla BioHealing over unapproved MedBed and BioHealer devices marketed for serious diseases.

    High risk
  21. King Systems Corp. dba Ambu, Inc.

    FDA warns Ambu's King Systems over unapproved King LTS-D airway device and pediatric website claims.

    High risk
  22. Integra LifeSciences Corporation

    FDA warned Integra LifeSciences over collagen-based medical devices made in Boston after an inspection found quality-system failures and endotoxin testing problems.

    High risk
  23. Edge Biologicals Inc.

    FDA cited Edge Biologicals Inc. for repeated quality-system violations in its IVD culture media devices, including unvalidated cleaning and sterilization.

    High risk
  24. Vitang Technology LLC

    Vitang Technology sold dental aligners designed with uncleared software without a new 510(k) and with quality system failures.

    High risk
  25. iRhythm Technologies, Inc.

    FDA warned iRhythm that its Zio AT cardiac monitor was illegally marketed after a 2022 inspection found unapproved changes and quality failures.

    High risk
  26. Steiner Biotechnology, LLC

    FDA found Steiner Biotechnology's implantable dental bone grafts had design, sterilization, and cleanroom failures and were marketed beyond cleared uses.

    High risk
  27. Sea-Long Medical Systems, LLC

    FDA warns Sea-Long Medical Systems over Treatment Hood quality failures and unapproved uses.

    High risk
  28. Abbott Point of Care Canada Limited

    FDA says Abbott Point of Care Canada marketed modified i-STAT cTnI cartridges without required FDA clearance.

    High risk
  29. Synovo Production, Inc.

    FDA warned Synovo Production of Fullerton, CA over unapproved cementless hip implants and quality system failures.

    High risk
  30. Olympus Medical Systems Corp.

    FDA warned Olympus Medical Systems about endoscope accessories for quality-system, complaint, packaging-seal, and reporting failures.

    High risk
  31. Fischer Analysen Instrumente Gmbh

    FDA warns Fischer Analysen Instrumente over quality system and reporting failures for PyloPlus UBT analyzers.

    Medium
  32. Wintech Medipro LLC

    FDA warns Wintech Medipro over unapproved surgical masks and broad quality system failures.

    High risk
  33. Getsch+Hiller Medizintechnik GmbH

    FDA warned Getsch+Hiller about unapproved reusable laparoscopic tips and missing quality records at its German plant.

    High risk
  34. MicroVention Costa Rica S.R.L.

    FDA says MicroVention Costa Rica's catheters and balloons are adulterated due to quality-system and process-validation failures.

    Medium
  35. Turkuaz Sağlik Hizmetleri Medikal Temizlik Kimyasa

    FDA warns Turkish ultrasound gel maker Turkuaz over broad quality-system violations found in 2022 inspection.

    High risk
  36. Olympus Medical Systems Corporation

    Olympus Medical Systems failed to submit timely Medical Device Reports for endoscope malfunctions, FDA says.

    High risk
  37. Aizu Olympus Co., Ltd.

    Aizu Olympus failed to validate endoscope designs and manufacturing processes and lacked MDR procedures, FDA says.

    High risk
  38. RoyalVibe Health Ltd.

    RoyalVibe Health marketed unapproved medical devices for cancer and other diseases and refused an FDA inspection.

    High risk
  39. Dollar Tree, Inc.

    FDA found severe rodent and bird infestation at Dollar Tree's Family Dollar warehouse, exposing foods, drugs, cosmetics, animal foods, and devices to contamination.

    High risk
  40. Forcemech International LLC

    Forcemech International, a powered wheelchair relabeler in Pearland, Texas, lacked quality system procedures and UDI labeling, FDA says.

    Medium
  41. Flawless Beauty and Skin

    FDA says Flawless Beauty and Skin marketed unapproved microneedling devices and failed to register as an initial importer.

    Medium
  42. Med Pen Concepts, LLC

    FDA warned Med Pen Concepts about unapproved plasma skin devices and quality-system failures.

    High risk
  43. JAS Diagnostics/Drew Scientific, Inc.

    FDA warned JAS Diagnostics/Drew Scientific over inadequate complaint handling, CAPA, process validation, design controls and nonconforming-product controls for IVD reagents.

    Medium
  44. Zyno Medical LLC

    FDA warns Zyno Medical over infusion pump and administration set quality violations and unapproved set changes.

    High risk
  45. InfuTronix LLC

    InfuTronix infusion pumps: complaint and quality-fix failures, an unreported correction, and administration set changes not cleared by FDA.

    High risk
  46. Skin Sheek

    Skin Sheek markets CLEAR, ERASE, LIFT and SILK skin devices without FDA clearance or approval, FDA says.

    High risk
  47. Unimicro Medical Systems-Shenzhen Co., Ltd.

    FDA warns Shenzhen maker of Veress needles that quality system violations make its devices adulterated and subject to U.S. import detention.

    High risk
  48. CardioQuip, LLC

    CardioQuip sold significantly modified cardiac heater-cooler devices without required FDA clearance and with quality system violations.

    High risk
  49. Wickimed Medical Equipment Manufacturing Co., Ltd.

    FDA warned China-based Wickimed over quality system failures in making sterile single-use electrodes, including unsterilized product labeled sterile.

    High risk
  50. Sunstar Americas, Inc.

    Sunstar Americas' water and quality failures led to contamination and recalls of oral rinses and dry-mouth devices.

    High risk